48 results
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
or any supplemented prospectus and/or amended registration statement.
5.8 All fees and expenses incident to the performance of or compliance
8-K
EX-2.1
TXMD
TherapeuticsMD Inc
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
than those incident to its formation and pursuant to the Transactions.
Section 5.7Disclosure Documents. The Schedule TO and the other Offer
8-K
EX-2.1
40z9gda
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
S-3ASR
EX-1.2
14h1d
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-1.1
2f31o6
16 Feb 21
Entry into a Material Definitive Agreement
8:35am
8-K
EX-1.1
bihg 71ndx
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-1.1
mos tm1fr5
13 Nov 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
zndizd8jyklci
29 Oct 19
Entry into a Material Definitive Agreement
8:52am
8-K
EX-1.1
odapyn7
3 Aug 18
Entry into a Material Definitive Agreement
9:28am
8-K
EX-1.1
79aav
15 Jul 15
Entry into a Material Definitive Agreement
12:00am